Cadrenal Therapeutics | EFFECT: Others
Cadrenal Therapeutics | 8-K: Current report
Cadrenal Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Cadrenal Therapeutics | 10-K: Annual report
Cadrenal Therapeutics | 8-K: Current report
Cadrenal Therapeutics | 8-K: Current report
Cadrenal Therapeutics | 8-K/A: Current report (Amendment)
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Cadrenal Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Raymond Murphy(5.49%)
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Quang X. Pham(48.57%),The PVBQ Living Trust(23.04%)
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Cadrenal Therapeutics | 8-K: Current report
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lisicki Robert
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MURPHY JOHN RAYMOND
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Szot Matthew K
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON GLYNN
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LOSORDO DOUGLAS W
No Data